Effects of serotonin on airways: recent developments
1995; Wiley; Volume: 50; Issue: 1 Linguagem: Inglês
10.1111/j.1398-9995.1995.tb02476.x
ISSN1398-9995
AutoresM. Cazzolau, Maria Gabriella Matera, Gennaro D’Amato, Francesca Rossi,
Tópico(s)Olfactory and Sensory Function Studies
ResumoAllergyVolume 50, Issue 1 p. 1-10 Free Access Effects of serotonin on airways: recent developments M. Cazzolau, Corresponding Author M. Cazzolau Division of Pneumology and Allergology, A. Cardarelli Hospital Division of Respiratory Clinical Pharmacology Unit, A. Cardarelli Hospital Institute of Pharmacology and Toxicology, Medical School, Second University, Naples, ItalyMario Cazzola, MD, Via del Parco Margherita 24 80121 Naples ItalySearch for more papers by this authorM. G. Matera, M. G. Matera Institute of Pharmacology and Toxicology, Medical School, Second University, Naples, ItalySearch for more papers by this authorG. D'Amato, G. D'Amato Division of Pneumology and Allergology, A. Cardarelli HospitalSearch for more papers by this authorF. Rossi, F. Rossi Institute of Pharmacology and Toxicology, Medical School, Second University, Naples, ItalySearch for more papers by this author M. Cazzolau, Corresponding Author M. Cazzolau Division of Pneumology and Allergology, A. Cardarelli Hospital Division of Respiratory Clinical Pharmacology Unit, A. Cardarelli Hospital Institute of Pharmacology and Toxicology, Medical School, Second University, Naples, ItalyMario Cazzola, MD, Via del Parco Margherita 24 80121 Naples ItalySearch for more papers by this authorM. G. Matera, M. G. Matera Institute of Pharmacology and Toxicology, Medical School, Second University, Naples, ItalySearch for more papers by this authorG. D'Amato, G. D'Amato Division of Pneumology and Allergology, A. Cardarelli HospitalSearch for more papers by this authorF. Rossi, F. Rossi Institute of Pharmacology and Toxicology, Medical School, Second University, Naples, ItalySearch for more papers by this author First published: January 1995 https://doi.org/10.1111/j.1398-9995.1995.tb02476.xCitations: 30AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Aitken MM, Sanford J. The effect of drugs on bovine and pulmonary vascular tissue. Br J Pharmacol 1970: 38: 443P. 2 Alving K, Ulfgren AK, Lundberg JM, Ahlstedt S. Effect of capsaicin on bronchial reactivity and inflammation in sensitized adult rats. Int Arch Allergy Appl Immunol 1987: 82: 377–9. 3 Austen KF. Histamine and other mediators of allergic reactions. In: M Samter, ed. Immunologic diseases. Boston : Little, Brown, 1971: 216–17. 4 Baumgartner RA, Wills-Karp M, Kaufman MJ, Munakata M, Hirshman C. Serotonin induces constriction and relaxation of the guinea pig airways. J Pharmacol Exp Ther 1990: 255: 165–73. 5 Bayol A, Benveniste J, Brink C, et al. Response and sensitivity of guinea-pig airway muscle preparations to 5-hydroxytryptamine during ontogenesis. Br J Pharmacol 1985: 85: 569–74. 6 Ben-Harari RR, Dalton BA, Osman R, Maayani S. Kinetic characterization of 5-hydroxytryptamine receptor desensitization in isolated guinea-pig trachea and rabbit aorta. J Pharmacol Exp Ther 1991: 257: 416–24. 7 Benveniste J, Henson PM, Cochrane CG. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med 1972: 136: 1356–77. 8 Bertram JF, Goldie RG, Papadimitriou JM, Paterson JW. Correlation between pharmacological responses and structure of human lung parenchyma strips. Br J Pharmacol 1983: 80: 107–14. 9 Bhattacharya BK. A pharmacological study on the effect of 5-hydroxytryptamine and its antagonists on the bronchial musculature. Arch Int Pharmacodyn 1955: 103: 357–69. 10 Booij-Noord H, Orie NGM, DE Vries K. Serotonin (5-hydroxytryptamine) inhalation in patients with chronic non-specific lung disease. Scand J Respir Dis 1969: 50: 301–8. 11 Bradley PB, Engel G, Feniuk W, et al. Proposal for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 1986: 25: 563–76. 12 Brocklehurst WE. The action of 5-hydroxytryptamine on smooth muscle. In: GP Lewis, ed. 5-Hydroxytryptamine. London : Pergamon Press, 1958: 172–6. 13 Buckner CK, DEA D. Liberati N, Krell RD. A pharmacologic examination of receptors mediating serotonin-induced bronchoconstriction in the anesthetized guinea pig. J Pharmacol Exp Ther 1991: 257: 26–34. 14 Burridge J, Butler A, Kilpatrick GJ. 5-HT3 receptors mediated depolarisation of guinea-pig isolated vagus nerve. Br J Pharmacol 1989: 96: 269P. 15 Capron A, Ameisen JC, Joseph M, Tonnel AB. Platelet effectors of hypersensitivity reactions. In: AB. KAY ed. Allergy and inflammation. London : Academic Press, 1987: 125–36. 16 Cazzola M, Assogna G, Lucchetti G, Cicchitto G, D'Amato G. Effect of ketanserin, a new blocking agent of 5-HT2 receptor, on airway responsiveness in asthma. Allergy 1990: 45: 151–3. 17 Cazzola M, Assogna G, Lucchetti G, D'Amato G. Respiratory functional effects of ketanserin in chronic obstruction of the airways. In: R Paoletti, PM Vanhoutte, N Brunello, FM Maggi, eds. Cardiovascular system, hypertension and serotonin antagonists. Dordrecht : Kluwer, 1990: 97–101. 18 Cazzola M, D'Amato G, Lobefalo G, et al. Ketanserin, a new blocking agent of serotonin S2-receptors. Respiratory functional effects in chronic obstruction of the airways. Chest 1987: 92: 863–6. 19 Cazzola M, Guidetti E, Sepe J, et al. Acute respiratory and cardiovascular effects of inhaled ketanserin in chronic obstructive pulmonary disease. A comparative study with intravenously administered ketanserin. Chest 1990: 97: 901–5. 20 Cazzola M, Matera MG. Farmaci antiserotoninergici ed iperreattivita bronchiale. Nuovo Boil Farmacol Clin 1991: 14: 119–24. 21 Cazzola M, Matera MG, Rossi F. Bronchial hyper-responsiveness and bacterial respiratory infections. Clin Ther 1991: 13: 157–71. 22 Cazzola M, Matera MG, Santangelo G. et al. Effect of the selective 5-HT2 antagonist ketanserin on adenosine-induced bronchoconstriction in asthmatic subjects. Immunopharmacology 1992: 23: 21–8. 23 Cazzola M, Spinazzi A, Santangelo G, et al. Acute effects of urapidil on airway response in hypertensive patients with chronic obstructive pulmonary disease. Drugs 1990: 40 (Suppl. 4): 71–2. 24 Cazzola M, Vaghi A, D'Amato G, Assogna G, Matera MG, Rossi F. Inhaled ketanserin, a selective blocking agent of 5-HT2 receptors, does not prevent ultra-sonically nebulised water induced bronchoconstriction in asthmatics. Eur Respir J 1992: 5 (Suppl. 15): S115. 25 Cerrina J, Boullet C, Labat C, Raffestin B, Benveniste J, Brink C. Pharmacology of isolated human bronchial muscle. Fed Proc 1983: 42: 906. 26 Chahl L. Substance P mediates atropine-sensitive response of guinea pig ileum to serotonin. Eur J Pharmacol 1983: 87: 485–9. 27 Chand N, Deroth L. In vitro comparison of drug responses on swine and rabbit airways. Physiologist 1978: 21: 19. 28 Chand N, Deroth L, Eyre P. Relaxant response of goat trachea to 5-hydroxytryptamine mediated by D-tryptamine receptors. Br J Pharmacol 1979: 66: 331–6. 29 Chand N. Eyre P. Spasmolytic actions of histamine in airway smooth muscle: an atypical H-receptor. Fed Proc 1977: 36: 1022. 30 Chand N, Eyre P. Spasmolytic action of histamine in airway smooth muscle of horse. Agents Actions 1978: 8: 191–8. 31 Choundry NB, Mcewan JR, Lavender EA, Williams AJ, Fuller RW. Human responses to inhaled capsaicin are not inhibited by granisetron. Br J Clin Pharmacol 1991: 31: 337–9. 32 Christian EP, Taylor GE, Weinreich D. Serotonin increases excitability of rabbit C-fiber neurons by two distinct mechanisms. J Appl Physiol 1989: 67: 584–91. 33 Cohen ML, Wittenauer LA. Serotonin receptor activation of phosphoinositide turnover in uterine, fundal, vascular, and tracheal smooth muscle. J Cardiovase Pharmacol 1987: 10: 176–81. 34 Colebatch HJH, Olsen CR, Nadel JA. Effect of histamine, serotonin and acetylcholine on the peripheral airways. J Appl Physiol 1966: 21: 217–26. 35 Cosgriff TM. Viruses and hemostasis. Rev Infect Dis 1989: 11 (Suppl. 4): S672–88. 36 Cushley MJ, Lee WH, Holgate ST. The effect of inhaled 5-hydroxytryptamine (5-HT, serotonin) on airway calibre in man. Br J Clin Pharmacol 1986: 22: 487–90. 37 Davies C, Kannan MS, Jones TR, Daniel EE. Control of human airway smooth muscle: in vitro studies. J Appl Physiol 1982: 53: 1080–7. 38 Delaunois L. Sergysels R, Boileau R, Diodatti J, Martin RR. Disturbances in pulmonary mechanics during serotonin perfusion. Bull Eur Physiopathol Respir 1979: 15: 593–602. 39 De Santis D, Matera MG, Cazzola M, Costantino M, D'Agostino B, Rossi F. Role of 5-HT2 receptors on adenosine-induced contraction of guinea-pig isolated trachea. Pharm Res 1992: 26 (Suppl. 1): 32. 40 Dey RD, Hoffpauir JM. Ultrastructural colocalization of the bioactive mediators 5-hydroxytryptamine and bombesin in endocrine cells of human fetal airways. Cell Tissue Res 1986: 246: 119–24. 41 Dixon M, Jackson DM, Richards IM. The effects of 5-hydroxytryptamine, histamine and acetylcholine on the reactivity of the lung of the anaesthetized dog. J Physiol (Lond) 1980: 307: 85–96. 42 Douglas WW, Ritchie JM. On the excitation of non-medullated afferent fibres in the vagus and aortic nerves by pharmacological agents. J Physiol (Lond) 1957: 138: 31–43. 43 Engel G, Gothert M, Hoyer D, Schlicker E, Hillinbrand K. Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HTIB binding sites. Naunyn Schmiedebergs Arch Pharmacol 1986: 332: 1–7. 44 Eyre P. The pharmacology of sheep tracheobronchial muscle: a relaxant effect of histamine on the isolated bronchi. Br J Pharmacol 1969: 36: 409–17. 45 Feniuk W, Humphrey PPA. Putative agonists and antagonists at 5-HT1-like receptors. In: PR Saxena, DI Wallis, W Wouters, P Bevan, eds. Cardiovascular pharmacology of 5-hydroxytryptamine. Dordrecht : Kluwer, 1990: 69–80. 46 Feniuk W, Humphrey PPA, Watts AD. 5-Hydroxy-tryptamine-induced relaxation of isolated mammalian smooth muscle. Eur J Pharmacol 1983: 96: 71–8. 47 Fozard JR. Neuronal 5-HT receptors in periphery. Neuro-pharmacology 1984: 23: 1473–86. 48 Frazer A, Maayani S, Wolfe BB. Subtypes of receptors for serotonin. Ann Rev Pharmacol Toxicol 1990: 30: 307–48. 49 Frossard N. Regulatory mechanisms of the contractile responses of rat airways to immunological stimulation. Clin Exp Allergy 1989: 19 (Suppl. 1): 33–42. 50 Gaddum JH, Hebb CO, Silver A, Swan AAB. 5-Hydroxytryptamine. Pharmacological action and destruction in perfused lungs. Q J Exp Physiol Cogn Med Sci 1953: 38: 255–62. 51 Garrison JC. Histamine, bradykinin, 5-hydroxytryptamine, and their antagonists. In: A Goodman Oilman, TW Rall, AS Nies, P Taylor, eds. Goodman and Oilman's pharmacological basis of therapeutics. 8th ed. New York : Pergamon Press, 1990: 575–99. 52 Gilbert MJ, Newberry NR. A 5-HT1-like receptor mediates a sympathetic ganglionic hyperpolarisation. Eur J Pharmacol 1987: 144: 385–8. 53 Girard JP, Moret P. Action de la sérotonine et de la bradykinine en aerosols chez les asthmatiques. Helv Med Acta 1963: 30: 520–6. 54 Gould VE, Linnoila RI, Memoli VA, Warren WH. Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias and neoplasms. Lab Invest 1983: 49: 519–37. 55 Hage E. Morphology and histochemistry of the normal and abnormal pulmonary endocrine cell. In: KL Becker, AF Gazdar, eds. The endocrine lung in health and disease. Philadelphia : WB Saunders, 1984: 193–209. 56 Hage E, Juel G. Endocrine-like cells of the pulmonary epithelium of the human lung. Cell Tissue Res 1977: 178: 39–48. 57 Hahn HL, Wilson AG, Graf PD, Fischer SP, Nadel JA. Interaction between serotonin and efferent vagus nerves in dog lung. J Appl Physiol 1978: 44: 144–9. 58 Hamon M, Emerit MB, el Mestikawy S, Gallissot MC, Gozlan H. Regional differences in the transduction mechanisms of 5-hydroxytryptamine receptors in the mammalian brain. In: PR Saxena, DI Wallis, W Wouters, P Bevan, eds. Cardiovascular pharmacology of 5-hydroxytryptamine. Dordrecht : Kluwer, 1990: 41–59. 59 Hartig PR. Molecular biology of the serotonin receptor family. In: R Paoletti, PM Vanhoutte, N Brunello, FM Maggi, eds. Serotonin. From cell biology to pharmacology and therapeutics. Dordrecht : Kluwer, 1990: 7–11. 60 Hechtman D, Lonergan EA, Staunton PB, Dennis RC, Shepro D. Pulmonary entrapment of platelets during acute respiratory failure. Surgery 1978: 83: 155–63. 61 Higashi H, Nishi S. 5-Hydroxytryptamine receptors of visceral primary afferent neurones on rabbit nodose ganglia. J Physiol (Lond) 1982: 323: 543–67. 62 Hirshman CA, Downes H. Experimental asthma in animals. In: EB Weiss, MS Segal, M Stein, eds. Bronchial asthma. Mechanisms and therapeutics. 2nd ed. Boston : Little, Brown, 1985: 280–99. 63 Houston DS, Shepherd DT, Vanhoutte PM. Adenine nucleotides, serotonin and endothelium-dependent relaxations to platelets. Am J Physiol 1985: 248: H389–95. 64 Humphrey PPA. Peripheral 5-hydroxytryptamine receptors and their classification. Neuropharmacology 1984: 23: 1503–10. 65 Islam MD, Melville GN. ULMER WT. Role of atropine in antagonizing the effect of 5-hydroxytryptamine (5-HT) on bronchial and pulmonary vascular system. Respiration 1974: 31: 47–59. 66 Johnson DE, Georgieff MK. Pulmonary neuroendocrine cells. Their secretory products and their potential role in health and chronic lung disease in infancy. Am Rev Respir Dis 1989: 140: 1807–12. 67 Keith IM, Will JA. Dynamics of the neuroendocrine cell-regulatory peptide systems in the lung: specific overview and new results. Exp Lung Res 1982: 3: 387–402. 68 Lauweryns JM, Cokelaere M, Theunynck P. Neuro-epithelial bodies in the respiratory mucosa of various mammals. Z Mikrosk Anat Forsch 1972: 135: 569–92. 69 Lauweryns JM, Peuskens JC. Neuro-epithelial bodies (neuroreceptor or secretory organs?) in human infant bronchial and bronchiolar epithelium. Anat Rec 1972: 172: 471–81. 70 Lauweryns JM, van Ranst L, Verhofstad AA. Ultrastructural localization of the serotonin in the intrapulmonary neuroepithelial bodies of neonatal rabbits by use of immunoelectron microscopy. Cell Tissue Res 1986: 243: 455–9. 71 Lauweryns JM, Van Ranst L, Verhofstad AAJ. Ultra-structural localization of serotonin in the intrapulmonary neuroepithelial bodies of neonatal rabbits by use of immunoelectron microscopy. Cell Tissue Res 1986: 243: 455–9. 72 Lauweryns JM, Van Lommel A. Morphometric analysis of hypoxia-induced synaptic activity in intrapulmonary neuroepithelial bodies. Cell Tissue Res 1982: 226: 201–14. 73 Lauweryns JM, Van Lommel A. Ultrastructure of nerve endings and synaptic junctions in rabbit intrapulmonary neuroepithelial bodies: a single and serial analysis. J Anat 1987: 151: 65–83. 74 Lemoine H, Kaumann AJ. Allosteric properties of 5-HT2 receptors in tracheal smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 1986: 333: 91–7. 75 Levitt RC, Mitzner W. Autosomal recessive inheritance of airway hyperreactivity to 5-hydroxytryptamine. J Appl Physiol 1989: 67: 1125–32. 76 Leysen JE, Niemegeers CJE, Van Neuten JM, Laduron PM. (3H) ketanserin (R41 468), a selective 3H-ligand of serotonin 2-receptor binding sites: binding properties, brain distribution and functional role. Mol Pharmacol 1982: 21: 301–14. 77 Lulich KM, Paterson JW. An in vitro study of various drugs on central and peripheral airways of the rat: a comparison with human airways. Br J Pharmacol 1980: 68: 633–6. 78 Maayani S, Sherman MR. Adenylate cyclase-linked 5-hydroxytryptamine receptors in the brain. In: R Paoletti, PM Vanhoutte, N Brunello, FM Maggi, eds. Serotonin. From cell biology to pharmacology and therapeutics. Dordrecht : Kluwer, 1990: 39–51. 79 Macquin-Mavier I, Jarreau PH, Istin N, Harf A. 5-Hydroxytryptamine-induced bronchoconstriction in the guinea-pig: effect of 5-HT2 receptor activation on acetylcho-line release. Br J Pharmacol 1991: 102: 1003–7. 80 Manzini S, Ballati D. 2-Chloroadenosine induction of vagally-mediated and atropine-resistant bronchomotor responses in anaesthetized guinea-pigs. Br J Pharmacol 1990: 100: 251–6. 81 Marcelle R. Potentiation réciproque de ractivité bron-choconstrictrice de l'histamine et de la 5-hydroxytryptamine chez le cobaye. Arch Int Physiol Biochim 1984: 92: 195–201. 82 Mathè AA, Aström A, Persson NA. Some broncho-constricting and bronchodilating responses of human isolated bronchi: evidence for existence of alpha-adreno-receptors. J Pharm Pharmacol 1971: 3: 905–10. 83 McCaiG DJ. Autonomic responses of the isolated, innervated trachea of the guinea-pig: interaction with the autonomic drugs histamine and 5-hydroxytryptamine. Br J Pharmacol 1986: 88: 239–48. 84 Moosavi H, Smith P, Heath D. The Feyrter cell in hypoxia. Thorax 1973: 28: 729–41. 85 Murphy TM, Munoz NM, Moss J, Blake JS, Mack MM, Leff AR. PAF-induced contraction of canine trachea mediated by 5-hydroxytryptamine in vivo. J Appl Physiol 1989: 66: 638–43. 86 Mylecharane EJ. Agonists and antagonists of 5-HT2 receptors. In: PR Saxena, DI Wallis, W Wouters, P Bevan, eds. Cardiovascular pharmacology of 5-hydroxytryptamine. Dordrecht : Kluwer, 1990: 81–100. 87 Neto FR. The depolarizing action of 5-HT on mammalian non-myelinated nerve fibres. Eur J Pharmacol 1978: 49: 351–6. 88 Nordström O, Delbro D. Adenosine-induced contractions of the isolated rat trachea is mediated by 5-hydroxytryptamine. Acta Physiol Scand 1986: 127: 557–8. 89 Offermeier J, Ariens EJ. Serotonin. I. Receptors involved in its action. Arch Int Pharmacodyn 1966: 164: 192–215. 90 Olson NC, Grizzle MK, Anderson DL. Effects of ketanserin on pulmonary hemodynamics, lung mechanics, and gas exchange in endotoxemic pigs. Am J Vet Res 1986: 47: 2193–6. 91 Panzani R. 5-Hydroxytryptamine (serotonin) in human bronchial asthma. Ann Allergy 1962: 20: 721–31. 92 Panzani R, Pascal N. L'action de la 5-hydroxytryptamine (serotonine) en aerosol chez les asthmatiques. Int Arch Allergy 1961: 18: 199–212. 93 Pauwels R. Hereditary factors in airway responsiveness. In: JA Nadel, R Pauwels, PD Snashall, eds. Bronchial hyperresponsiveness. Oxford : Blackwell Scientific, 1987: 337–41. 94 Pauwels RA, Van DER Straeten ME. An animal model for adenosine-induced bronchoconstriction. Am Rev Respir Dis 1987: 136: 374–8. 95 Pauwels R, Van DER Straeten M, Weyne J, Bazin H. Genetic factors in non-specific bronchial reactivity in rats. Eur J Respir Dis 1985: 66: 98–104. 96 Peroutka SJ, Snyder SH. Multiple serotonin receptors and their physiological significance. Fed Proc 1983: 42: 213–17. 97 Plowman L, Scheibner T, Sullivan CE. Neurochemicals in the infant lung. In: CL Armour, JL Black, eds. Mechanisms in asthma. Pharmacology, physiology and management. New York : Alan R Liss, 1988: 131–48. 98 Raffestin B, Cerrina J, Boullet C, Labat C, Ben-Veniste J, Brink C. Response and sensitivity of isolated human pulmonary muscle preparations to pharmacological agents. J Pharmacol Exp Ther 1985: 233: 186–94. 99 Rodbard S, Kira S. Lobar airway and pulmonary vascular effect of serotonin. Angiology 1972: 23: 188–97. 100 Roth BL, Chuang D. Multiple mechanisms of serotonergic signal transduction. Life Sci 1987: 41: 1051–64. 101 Roth BL, Nakaki T, Chang D-M, Costa E. Aortic recognition sites for serotonin (5-HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover. Neuropharmacology 1984: 23: 1225–34. 102 Saxena PR, Verdouw PD. 5-Carboxamide tryptamine, a compound with high affinity for 5-HT1 binding sites, dilates arterioles and constricts arteriovenous anastomoses. Br J Pharmacol 1985: 84: 533–54. 103 Schramm CM, Grunstein MM. Mechanisms of protein kinase C regulation of airway contractility. J Appl Physiol 1989: 66: 1935–41. 104 Selig WM, Bloomquist MA, Cohen ML, Fleisch JH. Serotonin-induced pulmonary responses in the perfused guinea pig lung: evidence for 5-HT2, receptor-mediated pulmonary vascular and airway smooth muscle constriction. Pulmon Pharmacol 1988: 1: 193–9. 105 Sheller JR, Holtzman MJ, Skoogh B-E, Nadel JA. Interaction of serotonin and ACh-mediated bronchoconstriction in canine lungs. J Appl Physiol 1982: 52: 964–6. 106 So SY, Lam WK, Kwan S. Selective 5-HT2 receptor blockade in exercise-induced asthma. Clin Allergy 1985: 15: 371–6. 107 Stahlman MT, Gray ME. Ontogeny of neuroendocrine cells in human fetal lung. I. An electron microscopic study. Lab Invest 1984: 51: 449–63. 108 Statkov PR. Lack of evidence for M- and D-serotonin receptors in the cat's isolated tracheal smooth muscle. Pharmacology 1969: 2: 176–80. 109 Stein M, Hirose T, Yasutake T, Khan MA. The effects of platelet amines on airway function. In: A Bouhuys, ed. Airway dynamics. Springfield , IL : Charles C Thomas, 1970: 283–5. 110 Steinberg H, Fisher AB. Serotonin in lung. In: WB Essman, ed. Serotonin in health and disease: clinical applications. Vol. V. Santa Rosa , CA : Spectrum Publications, 1978: 75–115. 111 Stott DJ, Roberts JA, Thomson NC, Ball SG. The effects of the 5-HT2 antagonist ketanserin in adult atopic asthma. Eur J Clin Pharmacol 1988: 35: 209–12. 112 Strum JM, Junod AF. Autoradiographic demonstration of (3H) 5-HT uptake by pulmonary endothelial cells. J Cell Biol 1972: 54: 456–67. 113 TiPS receptor nomenclature. 1992: Suppl.: 18. 114 Tonnesen P. Bronchial challenge with serotonin in asthmatics. Allergy 1985: 40: 136–40. 115 Tsutsumi Y, Osamura RY, Watanabe K, Yanaihara N. Simultaneous immunohistochemical localization of gastrin releasing peptide (GRP) and calcitonin (CT) in human bronchial endocrine-type cells. Virchows Arch A Pathol Anat Histopathol 1983: 400: 163–71. 116 Tsutsumi Y, Osamura RY, Watanabe K, Yanaihara N. Immunohistochemical studies on gastrin releasing peptide- and adrenocorticotropic hormone-containing cells in the human lung. Lab Invest 1983: 48: 623–32. 117 Vahi R, Baconnier P, Hasegawa B, Pride N, Milic-Emili J. Serotonin-induced flow limitation during passive expiration in cats. Am Rev Respir Dis 1985: 131: A326. 118 Van Nueten JM, Leysen JE, Vanhoutte PM, Janssen PAS. Serotonergic responses in vascular and nonvascular tissues. Arch Int Pharmacodyn Ther 1982: 256: 331–4. 119 Watts SW, Cohen ML. Characterization of the contractile serotonergic receptor in guinea pig trachea with agonists and antagonists. J Pharmacol Exp Ther 1992: 260: 1101–6. 120 Webber SE, Salonen RO, Widdicombe JG. Receptors mediating the effects of 5-hydroxytryptamine on the tracheal vasculature and smooth muscle of sheep. Br J Pharmacol 1990: 99: 21–6. 121 Weinreich D, Wonderlin WF. Inhibition of calcium-dependent spike after hyperpolarization increases excitability of rabbit visceral sensory neurones. J Physiol (Lond) 1987: 394: 415–27. 122 Yamamoto Y, Hasegawa H, Inoue F, Ikeda K, Ichiyama A. Serotonin in the lung. Demonstration of a close correlation to blood platelet. Agents Actions 1986: 18: 351–8. Citing Literature Volume50, Issue1January 1995Pages 1-10 ReferencesRelatedInformation
Referência(s)